Lexicon Pharmaceuticals Enters Into Agreement With TerSera Therapeutics for the Sale of XERMELO

    NEXT STORY
    Lexicon Realigns Business Around Research and Development Assets, with Focus on Phase 2 LX9211 Neuropathic Pain Program
    PREV STORY
    QuestCap Secures Exclusive Sales Rights for Emergency Use Authorized COVID-19 Lateral Flow Antibody Test Kit
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Chembio Awarded CDC Contract for Zika, Dengue, and Chikungunya Surveillance Testing in India, Peru, Guatemala and Haiti

    MEDFORD, N.Y., Sept. 28, 2016 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader ...

    author_avatar
    NASDAQ Market News

    First Patients Enrolled in UK’s Early Access to Medicines Scheme for Santhera’s Raxone® in Duchenne Muscular Dystrophy (DMD)

    Liestal, Switzerland, September 11, 2017 - Santhera Pharmaceuticals (SIX: SANN) announces enrollment of first DMD ...

    author_avatar
    NASDAQ Market News

    Blood Sugar Blaster Reviews: Negative Side Effects or Legit Ingredients?

    author_avatar
    NASDAQ Market News